SITE MAP 
  HOME  
PHARMA
BIO TECHNOLOGY
MEDICAL TECHNOLOGY
  JOBS  
  FREE SUBSCRIPTION  
  Tuesday, May 13, 2008 SEARCH     
BIO AUSTRALIA
BIO CHINA
BIO INDIA
BIO INDONESIA
BIO JAPAN
BIO KOREA
BIO MALAYSIA
BIO NEW ZEALAND
BIO PHILIPPINES
BIO SINGAPORE
BIO TAIWAN
BIO THAILAND

Japanese medical technology
PRIME NEWS
FDA approves updated labeling for Abilify
The Food and Drug Administration has approved updated labeling for Abilify, a drug made jointly by Bristol-Myers Squibb and Japans Otsuka Pharmaceuticals
Japan patent office licenses Xennex's GeneCards
The Japan Patent Office has licensed GeneCards by Xennex. The company also announced that it has selected Bioscene Informatics as its exclusive partner for the distribution of GeneCards in Japan
TODAY'S NEWS
  Aurobindo Pharma to market 9 products in South Africa
  Spectrum Pharma sells injectable generic drugs to Sagent Pharma
  Merck, Schering-Plough present results of cholesterol drug
  Ranbaxy, Merck sign drug discovery, development agreement
  Over 1200 firms attend API & INTERPHEX China
  Helicon group secures China rights For Collatamp G

BioSpectrum Japan is uniquely positioned as a specialized information platform for Japanese medical technology articles. It brings to you comprehensive coverage and useful Japan medical news in the areas of pharmaceuticals industry in Japan, Japanese medical technology, Japan medical devices and Biotech.
Advertisement
 
Digital Mag
Updated Fortnightly

Issue: April 30, 2008
Current Issue
View / Download
Top Story
China steps up the pace: India and China are racing to become lucrative pharmaceutical markets for global players
 
 
 
Print Edition
Issue: May 2008
Read Online
Free Subscription
 
 
Get the latest news on life sciences in your mail box
Name
E-Mail Id
 
 
Advertisement





















 

NEWS
FDA approves updated labeling for Abilify
The Food and Drug Administration has approved updated labeling for Abilify, a drug made jointly by Bristol-Myers Squibb and Japans Otsuka Pharmaceuticals
Japan patent office licenses Xennex's GeneCards
The Japan Patent Office has licensed GeneCards by Xennex. The company also announced that it has selected Bioscene Informatics as its exclusive partner for the distribution of GeneCards in Japan
FEATURES
Collaboration with local CROs is a good strategy
Ever Progressing System (EPS) International, a leading Japanese CRO is primarily involved in activities like clinical research, site management and pre-clinical businesses
We bridge manufacturer and wholesaler:RIJ
Research & Innovation Japan, located in Shiroi, North East of Tokyo, is a one-year-old consulting company that helps foreign companies penetrate into the Japanese market
PEOPLE
Japanese stem cell scientist joins Gladstone Institutes
Japanese stem cell scientist, Dr Shinya Yamanaka has joined the US-based Gladstone Institute, where he will pursue human applications of his research creating embryonic cells from adult cells
Sosei restructures Board
Sosei has changed its Board of Directors. The new non-executive directors include Dr Declan Doogan, Mr Eiji Katayama, Dr Alan Lewis and Mr Isao Muramatsu
EVENTS
TriNation Health Tech Forum: American Cities to share med tech advances with Japan
The Forum is focused on bringing together the medical devices and e-health technology communities of Western Canada, Washington State and Oregon with delegates from Japan
Medidata participates in clinical data workshop in Japan
Medidata Solutions announced that its top executives will present at the 11th Annual Workshop for Clinical Data Management in Tokyo, Japan
R & D
SciClone, Sigma-Tau report promising results in HCV trial
SciClone Pharmaceuticals and Sigma-Tau have reported promising interim data from phase III clinical trial of ZADAXIN, intended to treat patients with hepatitis C virus
Faust Pharma signs research agreement with Takeda
Faust Pharmaceuticals, a clinical-stage product company specializing in the discovery and development of drugs for diseases of the nervous system from France has entered into a research agreement with Takeda Pharmaceutical Company.
POLICIES
Chugai's arthritis drug, Actemra gets approval in Japan
Tokyo-based Chugai Pharmaceutical said the humanized anti-human interleukin-6 receptor monoclonal antibody, Actemra is approved by the Japanese authority to treat arthritis
CV, Astellas get FDA approval for Lexiscan injection
CV Therapeutics and the US arm of Japanese firm Astellas Pharma have received approval from the US FDA for Lexiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging
PRODUCTS
AnGes launches Naglazyme in Japan
Japanese biopharmaceutical company AnGes has launched Naglazyme (galsulfase) for patients with the genetic disease mucopolysaccharidosis VI
BioGaia AB launches probiotic products in Japan
Swedish biotechnology company BioGaia AB has said that it has decided to go on with the launch of its probiotic products on the Japanese market.
TRENDS & ANALYSIS
Japan is world's second largest medical devices market
With an increasing number of patients requiring long-term care and the advent of the elderly health insurance system, the demand for medical devices in very high in Japan
Japan tightens drug approval processes
The country is working towards moving more into line with the western countries regarding regulatory laws
 
Advertisement





 
Google
BioSpectrumAsia.com BioSpectrumIndia.com Web

About BioSpectrum | How to Advertise | Jobs at BioSpectrum | Contact Us | Privacy Statement



CyberMedia Network Websites


[Voice&Data]  [PCQuest]  [CIOL]  [Dataquest]  [Living Digital]  [IDC India]
[CIOL Shop]  [DQ Channels]  [The DQweek]  [CyberMedia Dice]  
[CyberMedia Events] [CyberMedia Digital]  [Cyber Astro]  [CyberMedia India]  [Global Services]  [BioSpectrum]

 
Copyrights are reserved for BioSpectrum ; Designed by : Altered Black